Advertisement

Topics

Trial Results Demonstrate Reductions in Lactose Intolerance Symptoms

06:07 EDT 7 Aug 2017 | PharmPro

Ritter Pharmaceuticals reports further analysis from its Phase 2b/3 trial results demonstrating significant reductions in lactose intolerance symptoms. Analysis shows clinically meaningful benefit from symptoms, global patient-reported, and real-world assessments.
Contributed Author: 
Ritter Pharmaceuticals, Inc.

Original Article: Trial Results Demonstrate Reductions in Lactose Intolerance Symptoms

NEXT ARTICLE

More From BioPortfolio on "Trial Results Demonstrate Reductions in Lactose Intolerance Symptoms"

Quick Search
Advertisement